Published in J Virol on August 01, 1979
Transcription from the SV40 early-early and late-early overlapping promoters in the absence of DNA replication. EMBO J (1983) 2.55
Genome-wide identification of transcription start sites, promoters and transcription factor binding sites in E. coli. PLoS One (2009) 2.48
Characterization of the 5'-terminal cap structures of early simian virus 40 mRNA. J Virol (1980) 1.95
DNA sequences similar to those around the simian virus 40 origin of replication are present in the monkey genome. Proc Natl Acad Sci U S A (1981) 1.94
Initiation of transcription by RNA polymerase II in permeable, SV40-infected or noninfected, CVI cells; evidence for multiple promoters of SV40 late transcription. Nucleic Acids Res (1981) 1.71
Simian virus 40 early mRNA's in lytically infected and transformed cells contain six 5'-terminal caps. J Virol (1981) 1.25
Mapping the in vivo arrangement of nucleosomes on simian virus 40 chromatin by the photoaddition of radioactive hydroxymethyltrimethylpsoralen. J Virol (1982) 0.90
Accurate transcription of simian virus 40 chromatin in a HeLa cell extract. J Virol (1982) 0.86
An empirical strategy to detect bacterial transcript structure from directional RNA-seq transcriptome data. BMC Genomics (2015) 0.77
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
A new method for sequencing DNA. Proc Natl Acad Sci U S A (1977) 250.51
The genome of simian virus 40. Science (1978) 24.46
Complete nucleotide sequence of SV40 DNA. Nature (1978) 24.07
Spliced early mRNAs of simian virus 40. Proc Natl Acad Sci U S A (1978) 18.67
Rates of formation and thermal stabilities of RNA:DNA and DNA:DNA duplexes at high concentrations of formamide. Nucleic Acids Res (1977) 15.92
Purification and further properties of single-strand-specific nuclease from Aspergillus oryzae. Eur J Biochem (1973) 13.54
THE NUCLEIC ACID OF SIMIAN VIRUS 40. Virology (1964) 12.56
Heterogeneity and 5'-terminal structures of the late RNAs of simian virus 40. J Mol Biol (1978) 7.64
Sequence of a mouse germ-line gene for a variable region of an immunoglobulin light chain. Proc Natl Acad Sci U S A (1978) 6.80
Structure of replicating simian virus 40 deoxyribonucleic acid molecules. J Virol (1971) 6.74
Cell-free translation of simian virus 40 early messenger RNA coding for viral T-antigen. Proc Natl Acad Sci U S A (1977) 6.57
Simian virus 40 early mRNA's. I. Genomic localization of 3' and 5' termini and two major splices in mRNA from transformed and lytically infected cells. J Virol (1979) 5.93
Intervening sequence of DNA identified in the structural portion of a mouse beta-globin gene. Proc Natl Acad Sci U S A (1978) 4.02
Rapid sequence determination of late simian virus 40 16S mRNA leader by using inhibitors of reverse transcriptase. Proc Natl Acad Sci U S A (1979) 3.16
Primary activation of the vitellogenin gene in the rooster. J Biol Chem (1977) 3.14
Methylated simian virus 40-specific RNA from nuclei and cytoplasm of infected BSC-1 cells. Proc Natl Acad Sci U S A (1975) 2.81
Improved computer program data for the resolution and fractionation of macromolecules by isokinetic sucrose density gradient sedimentation. Anal Biochem (1974) 2.06
Preparative fractionation of DNA restriction fragments by reversed phase column chromatography. Proc Natl Acad Sci U S A (1976) 1.77
Characterization of two SV40 early mRNAs and evidence for a nuclear "prespliced" RNA species. Nucleic Acids Res (1978) 1.57
Nucleotide sequence of the simian virus 40 small-t gene. Proc Natl Acad Sci U S A (1978) 1.41
Preparative fractionation of DNA restriction fragments by high pressure column chromatography on RPC-5. Nucleic Acids Res (1976) 1.37
Characterization of the 5'-terminal capped structures of late simian virus 40-specific mRNA. J Virol (1978) 1.36
The sequences between 0.59 and 0.54 map units on SV40 DNA code for the unique region of small t antigen. Cell (1978) 1.34
Capping structures of simian virus 40 19S and 16S mRNAs. Nucleic Acids Res (1977) 1.29
Properties of simian virus 40 transcriptional intermediates isolated from nuclei of permissive cells. J Virol (1977) 1.25
Preparative separation of the complementary strands of DNA restriction fragments by alkaline RPC-5 chromatography. Nucleic Acids Res (1978) 1.14
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther (1976) 9.13
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci U S A (2002) 8.72
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science (1989) 7.90
Structure of replicating simian virus 40 deoxyribonucleic acid molecules. J Virol (1971) 6.74
Origin and direction of simian virus 40 deoxyribonucleic acid replication. J Virol (1972) 6.39
Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med (1987) 5.58
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med (1995) 4.06
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. J Virol (1997) 3.64
Intermediate in SV40 DNA chain growth. Nat New Biol (1972) 3.38
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med (2000) 3.32
Phosphorylation of p53 serine 15 increases interaction with CBP. J Biol Chem (1998) 2.97
Posterior tracheal wall perforation during percutaneous dilational tracheostomy: an investigation into its mechanism and prevention. Chest (1999) 2.91
Resolutions and identification of the core deoxynucleoproteins of the simian virus 40. Biochem Biophys Res Commun (1973) 2.90
Sequential protein synthesis following vaccinia virus infection. J Virol (1968) 2.89
Direct interaction of human TFIID with the HIV-1 transactivator tat. Nature (1994) 2.87
Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci U S A (1996) 2.77
Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med (1990) 2.65
Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals. J Virol (1989) 2.62
Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis (1994) 2.60
Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol Cell Biol (2000) 2.58
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci U S A (2001) 2.48
Inhibition in the joining of DNA intermediates to growing simian virus 40 chains. J Virol (1973) 2.44
JC virus enhancer-promoter active in human brain cells. Science (1984) 2.36
Sequential formation of vaccinia virus proteins and viral deoxyribonucleic acid replication. J Virol (1967) 2.34
Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNA. Cell (1982) 2.32
Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection. Mol Biol Evol (1999) 2.32
Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res (1999) 2.25
Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J Neurochem (1997) 2.13
Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry (1998) 2.01
Simian virus 40 major late promoter: an upstream DNA sequence required for efficient in vitro transcription. Mol Cell Biol (1984) 1.94
Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation (2000) 1.84
Selective radiolabeling of cell surface proteins to a high specific activity. Biochemistry (1987) 1.74
Metabolic properties of early and late vaccinia virus messenger ribonucleic acid. J Virol (1967) 1.70
The effect of inflation on the cost of journals on the Brandon list. Bull Med Libr Assoc (1980) 1.67
Specific initiation site for simian virus 40 deoxyribonucleic acid replication. J Virol (1972) 1.66
Efficacy of various forms of fixation of transverse fractures of the patella. J Bone Joint Surg Am (1980) 1.61
Infant botulism: clinical spectrum and epidemiology. Pediatrics (1980) 1.58
Extracellular FGF-1 acts as a lens differentiation factor in transgenic mice. Development (1995) 1.53
Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport. J Virol (1989) 1.53
Simian virus 40 guanine-cytosine-rich sequences function as independent transcriptional control elements in vitro. Mol Cell Biol (1984) 1.52
A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52
Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol (1996) 1.50
Envelope-specific antibodies in the saliva of individuals vaccinated with recombinant HIV-1 gp160. J Acquir Immune Defic Syndr (1992) 1.49
Construction and characterisation of a yeast artificial chromosome library containing three haploid maize genome equivalents. Plant Mol Biol (1992) 1.49
Clinical and pathologic features of cloned transgenic calves and fetuses (13 case studies). Theriogenology (1999) 1.46
Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug. J Clin Invest (1996) 1.46
Unwinding of parental strands during simian virus 40 DNA replication. J Virol (1973) 1.43
A 36-kilodalton cellular transcription factor mediates an indirect interaction of human T-cell leukemia/lymphoma virus type I TAX1 with a responsive element in the viral long terminal repeat. Mol Cell Biol (1990) 1.42
The SV40 DNA template for transcription of late mRNA in viral nucleoprotein complexes. Cell (1977) 1.42
Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci U S A (1996) 1.41
Patient preferences and the bedside manner. Med Educ (1982) 1.41
Characterization of Simian virus 40 DNA component II during viral DNA replication. J Mol Biol (1973) 1.40
Biochemical changes in phytohemagglutinin stimulated human lymphocytes. Exp Cell Res (1966) 1.39
In vitro transcription initiation by purified RNA polymerase II within the adenovirus 2 major late promoter region. J Biol Chem (1984) 1.38
Occurrence and properties of a chromatin-associated F1-histone phosphokinase in mitotic Chinese hamster cells. Biochemistry (1972) 1.38
Adenoviral vector infection of the human exocrine pancreas. Arch Surg (1997) 1.38
Assessing patient pain during dental laser treatment. J Am Dent Assoc (1993) 1.37
Passive hemagglutination test for detection of antibodies to human immunodeficiency virus type 1 and comparison of the test with enzyme-linked immunosorbent assay and Western blot (immunoblot) analysis. J Clin Microbiol (1989) 1.36
Therapy for painful cutaneous leiomyomas. J Am Acad Dermatol (1985) 1.36
Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus. J Immunol (1996) 1.34
Superhelix density of replicating simian virus 40 DNA molecules. J Mol Biol (1974) 1.34
Chemical modification of simian virus 40 DNA by reaction with a water-soluble carbodiimide. J Virol (1976) 1.31
America's best medical schools: a critique of the U.S. News & World Report rankings. Acad Med (2001) 1.30
Proximal and distal domains that control in vitro transcription of the adenovirus IVa2 gene. Proc Natl Acad Sci U S A (1984) 1.30
Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitors. Virology (1992) 1.29
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. Eur J Cancer (2011) 1.29
Mapping of transcription sites of simian virus 40-specific late 16S and 19S mRNA by electron microscopy. Proc Natl Acad Sci U S A (1977) 1.28
DNA affinity labeling of adenovirus type 2 upstream promoter sequence-binding factors identifies two distinct proteins. Mol Cell Biol (1988) 1.27
Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite. Arch Biochem Biophys (1999) 1.26
Evidence for placental abnormality as the major cause of mortality in first-trimester somatic cell cloned bovine fetuses. Biol Reprod (2000) 1.26
What are the implications of variation in root hair length on tolerance to phosphorus deficiency in combination with water stress in barley (Hordeum vulgare)? Ann Bot (2012) 1.26
Properties of simian virus 40 transcriptional intermediates isolated from nuclei of permissive cells. J Virol (1977) 1.25
Persistence of four related human immunodeficiency virus subtypes during the course of zidovudine therapy: relationship between virion RNA and proviral DNA. J Virol (1994) 1.25
A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice. Drug Metab Dispos (1985) 1.24
The oxygen free radical system: a fundamental mechanism in the production of myocardial necrosis. Prog Cardiovasc Dis (1986) 1.23
A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem Res Toxicol (2001) 1.23
Expression of a truncated FGF receptor results in defective lens development in transgenic mice. Development (1995) 1.22
Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus. J Virol (1989) 1.21
Efficient transcription of a compact nucleoprotein complex isolated from purified simian virus 40 virions. J Virol (1980) 1.21
Studies of polyoma virus DNA: cleavage map of the polyoma virus genome. J Virol (1975) 1.20
Characterization of simian virus 40 tsA58 transcriptional intermediates at restrictive temperatures: relationship between DNA replication and transcription. J Virol (1977) 1.20
Mitochondrial tyrosine nitration precedes chronic allograft nephropathy. Free Radic Biol Med (2001) 1.19
Salicylate poisoning complicated by fluid retention. Clin Toxicol (1976) 1.15
Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma. J Clin Oncol (1999) 1.15
Regulation of simian virus 40 early and late gene transcription without viral DNA replication. J Virol (1979) 1.14
Cloning of a carcinoembryonic antigen gene family member expressed in leukocytes of chronic myeloid leukemia patients and bone marrow. Cancer Res (1990) 1.14
Separation of isolated Chinese hamster metaphase chromosomes into three size-groups. J Mol Biol (1968) 1.14
Identification of a downstream sequence and binding protein that regulate adenovirus major late promoter transcription in vitro. J Biol Chem (1988) 1.13
Mapping 5' termini of JC virus late RNA. J Virol (1986) 1.13
Expression profiling of acetaminophen liver toxicity in mice using microarray technology. Biochem Biophys Res Commun (2001) 1.12
Molecular cloning of a gene belonging to the carcinoembryonic antigen gene family and discussion of a domain model. Proc Natl Acad Sci U S A (1987) 1.12
Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer. Arch Surg (1999) 1.12
F1-histone modification at metaphase in Chinese hamster cells. Exp Cell Res (1972) 1.11
Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J Neurochem (1995) 1.10
Hin D restriction mapping of upaired regions in simian virus 40 superhelical DNA I: considerations regarding structure-function relationships. J Virol (1976) 1.10